Login
$CNMD
$49.35 +$0.00 (0.0%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Patrick J. Beyer Also a director
President and Chief Executive Officer
60 Since 2025
1 year
$7,634,873
John E. Gallagher
Executive Vice President, Chief Financial Officer
Title from the Form 8-K dated Jul 15, 2026
Not stated Not stated Not reported
Hollie Foust
General Counsel & Corp Sec
Title from the Form 4 dated Nov 4, 2026
51 Not stated $1,842,776
Richard Glaze
Chief Information Officer
60 Since 2023
3 years
Not reported
John David Ferrell
EVP, Human Resources
58 Since 2022
4 years
Not reported
Brent Lalomia
EVP, Regulatory Affairs, Quality Assurance, Clinical Affairs, Commercial Operations, and IT
51 Since 2025
1 year
$1,662,776
Peter K. Shagory
EVP, Strategy and Corporate Development
57 Since 2015
11 years
$1,563,789
Andrew Moller
VP Corporate Controller
Title from the Form 4 dated Mar 2, 2026
51 Not stated Not reported
Johonna Pelletier
Treasurer and VP, Tax
53 Since 2015
11 years
Not reported
Matthew Schabacker
VP and General Manager, U.S. Advanced Surgical
45 Since 2025
1 year
Not reported
Kimberly Lockwood
Interim Corporate Controller and Senior Director, Financial Reporting and Controls
Title from the Form 8-K dated Jun 17, 2026
Not stated Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 7, 2026 · updated by the 8-K of May 20, 2026

Directors
10
serving now
Independent
3 of 3
stated in the proxy; 7 not stated
Average tenure
5.7 years
from year joined
CEO also chairs the board
No
LaVerne H. Council
Director Age On board Independent Committees Other public boards 2025 pay Source
LaVerne H. Council
64 2019
7 years
Not stated
Compensation Corporate Governance and Nominating · Chair
Thomson Reuters Corporation $308,004
Patrick J. Beyer
60 2025
1 year
Not stated None stated Bioventus Inc. Paid as CEO
David Bronson
72 2015
11 years
Not stated None stated None stated $282,134
Charles M. Farkas
74 2014
12 years
Not stated
Corporate Governance and Nominating Strategy · Chair
None stated $278,746
Mark Kaye
46 2025
1 year
Not stated
Audit Strategy
None stated $310,733
Kim Kelderman
58 2025
1 year
Not stated
Corporate Governance and Nominating Strategy
None stated $161,721
Barbara J. Schwarzentraub
60 2019
7 years
Not stated
Audit · Chair Compensation
None stated $290,356
Brian Concannon
Not stated Not stated Independent None stated None stated $279,994
Celine Martin Joined Jul 1, 2026
- - Independent
Audit Committee Strategy Committee
- -
Jeff Mirviss Joined Jul 1, 2026
- - Independent
Compensation Committee Corporate Governance and Nominating Committee
- -

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.

No related-party transactions disclosed

The proxy filed Apr 7, 2026 states there were none.

Read it in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support